Document:

Exhibit 10.1

 

AMENDMENT
AGREEMENT AND WAIVER

 

This
Amendment Agreement and Waiver (this “Agreement”), is made and entered into as of December 1, 2016, by and
between Ener-Core, Inc., a Delaware corporation (the “Company”), and [BUYER] (the “Buyer”).
All capitalized terms used herein but not defined shall have the meanings ascribed to such terms in the Purchase Agreement (as
defined below).

 

WHEREAS,
the Company and the Buyer entered into that certain Securities Purchase Agreement, dated November 23, 2016 (including the exhibits
and disclosure schedules thereto, the “Purchase Agreement”), pursuant to which the Buyer agreed to purchase
the Initial Note(s) and Initial Warrant(s) in the amounts set forth on the Schedule of Buyers thereto;

 

WHEREAS,
the Company and certain holders of (i) Senior Secured Convertible Notes (the “April 2015 Notes”) issued to
such holders pursuant to either that certain Securities Purchase Agreement dated as of April 22, 2015, by and among the Company
and the investors listed on the signature pages thereto and (ii) Senior Secured Convertible Notes (together with the April 2015
Notes, the “2015 Notes”) issued to such holders pursuant to either that certain Securities Purchase Agreement
dated as of May 7, 2015, by and among the Company and the investors listed on the signature pages thereto, intend to enter into
Amendment Agreements in the form attached hereto as Exhibit 1 (the “Amendment Agreements”) pursuant
to which certain holders of the 2015 Notes will approve of the amendment and restatement of such 2015 Notes;

 

WHEREAS,
the Company and the parties that intend to execute the Amendment Agreements noted that the terms of the form of Amendment Agreement,
in the form filed on November 25, 2016 as an exhibit to the Company’s Current Report on Form 8-K, did not conform to the
business understanding of such parties and, as such, the Company and such parties desire to revise the Amendment Agreements to
contemplate the issuance of additional warrants (the “Additional Warrants”) to the holders of the 2015 Notes
in connection with the amendment and restatement of such 2015 Notes (as amended and restated, the “Amended and Restated
2015 Notes”), and clarify that the principal amount of such Amended and Restated 2015 Notes shall be increased to reflect
an original issue discount;

 

WHEREAS,
the Buyer is aware of the foregoing revisions to the Amendment Agreements and desires to waive certain effects resulting from
such revisions, as well as to approve certain additional conforming amendments to the Purchase Agreement;

 

WHEREAS,
pursuant to Section 9(e) of the Purchase Agreement, any provision of the Purchase Agreement may be amended and the observance
thereof may be waived only with the written consent of (i) the Company and (ii) the holders of at least a majority the aggregate
number of the Conversion Shares and the Warrant Shares issued or issuable under the Notes (calculated using the Initial Conversion
Price) and Warrants (without regard to any limitation on conversion or exercise set forth therein), and shall include Empery Asset
Master, Ltd. (“Empery”) so long as Empery or any of its affiliates holds any Securities;

 

WHEREAS,
any amendment or waiver effected in accordance with Section 9(e) of the Purchase Agreement is binding upon each holder of Securities
and the Company; and

 

     

     

    

 

WHEREAS,
the parties hereto wish to amend the Purchase Agreement as set forth below.

 

NOW,
THEREFORE, in consideration of the mutual covenants
and agreements set forth herein, and for other good and valuable consideration, the receipt and sufficiency of which are hereby
acknowledged, the parties hereto agree as follows:

 

1.     
Waiver of Effect of Amendment Agreements. The Buyer hereby consents to the waiver of, and hereby irrevocably waives, the
effect of the issuance of the Additional Warrants pursuant to the Amendment Agreements, as revised by the Company and the parties
thereto, on any representation, warranty or covenant in the Purchase Agreement relating to the capitalization of the Company and
any obligation of the Company to issue securities directly or indirectly contemplated by the Amendment Agreements.

 

2.     
Amendments to Purchase Agreement.

 

(a)          Additional Issuances and Registrations of Securities. The definition of “Excluded Securities” in Section
4(r) of the Purchase Agreement is hereby amended and restated as follows:

 

“(y)
“Excluded Securities” means any shares of Common Stock or Options (as defined below) issued or issuable: (i)
in connection with any Approved Stock Plan, (ii) upon conversion of the Notes or exercise of the Warrants; provided, that the
terms of such Notes and Warrants are not amended, modified or changed on or after the date hereof, (iii) upon exercise of any
Options or Convertible Securities which are outstanding on the day immediately preceding the date hereof; provided, that the terms
of such Options or Convertible Securities are not amended, modified or changed on or after the Subscription Date (other than pursuant
to the amendment and restatement of certain notes of the Company issued during April 2015 and May 2015 contemplated to occur contemporaneously
with the issuance of the Notes and Warrants (the “Amended and Restated Notes”), (iv) pursuant to that certain
purchase agreement dated September 1, 2016 or upon exercise of such additional Options and (v) upon exercise of the warrants to
be issued to the holders of the Amended and Restated Notes upon the amendment and restatement thereof”

 

(b)         Form of Notes. The definition of “Permitted Indebtedness” in Section 30 of the Form of Senior Secured
Notes attached as Exhibit A to the Purchase Agreement is hereby amended and restated as follows:

 

“(aa)
“Permitted Indebtedness” means (i) Indebtedness evidenced by this Note and the Other Notes, (ii) trade payables
incurred in the ordinary course of business consistent with past practice, (iii) Indebtedness incurred by the Company that is
made expressly subordinate in right of payment to the Indebtedness evidenced by this Note, as reflected in a written agreement
acceptable to the Required Holders and approved by the Required Holders in writing, and which Indebtedness does not provide at
any time for (a) the payment, prepayment, repayment, repurchase or defeasance, directly or indirectly, of any principal or premium,
if any, thereon until ninety-one (91) days after the Maturity Date or later and (b) total interest and fees at a rate in excess
of twelve percent (12.0%) per annum, (iv) Indebtedness secured by Permitted Liens described in clauses (iv) of the definition
of Permitted Liens, (v) deemed Indebtedness arising from one or more operating leases, including, without limitation, the leases
for one or more test turbines from Dresser-Rand, but only if such lease, if secured, is secured solely by such test turbine, (vi)
Indebtedness incurred pursuant to the Backstop Agreement, (vii) Indebtedness by the notes issued pursuant to the Securities Purchase
Agreement dated as of September 1, 2016 by and among the Company and the investors thereto, as subsequently amended, restated
or modified thereafter), (viii) the Additional Notes issued prior to or on the Initial Closing Date, provided that the Indebtedness
evidenced by the Additional Notes is not increased, refinanced, amended, changed or modified on or after the date of issuance
thereof and (ix) the guarantees pursuant to the Guaranty Agreements.”

 

    	 	2	 

     

    

 

3.     
Acknowledgement. The Buyer understands and acknowledges that the Company will proceed with the Initial Closing in reliance
on this Agreement. In connection therewith, the Buyer hereby represents and warrants to the Company that: (i) the Buyer has the
full right, power and authority to execute and deliver this Agreement, and (ii) this Agreement has been duly and validly authorized,
executed and delivered on behalf of the Buyer and, subject to Section 4 of this Agreement, shall constitute the legal, valid and
binding obligation of the Buyer, enforceable against the Buyer in accordance with its terms.

 

4.     
Full Force and Effect. This Agreement shall be construed in connection with and as part of each Amendment Agreement, and
all terms, conditions, and covenants set forth in each Amendment Agreement and each other applicable instrument and agreement
identified therein, as applicable, except as herein waived, are hereby ratified and confirmed and shall remain in full force and
effect.

 

5.     
Counterparts. This Agreement may be executed in several counterparts, each of which shall constitute an original and all
of which, when taken together, shall constitute one instrument.

 

6.     
Construction. This Agreement shall be construed in accordance with the laws of the State of New York, without giving effect
to any choice of law or conflict of law provisions or rules.

 

7.     
Legend. THIS AGREEMENT DOES NOT, AND SHALL NOT, CONSTITUTE AN OFFER OF ANY OF THE COMPANY’S SECURITIES, INCLUDING
THE COMPANY’S COMMON STOCK, FOR SALE.

 

8.     
Effective Date. This Agreement shall be deemed effective as of the latest date of the execution of: (a) this Agreement,
(b) the substantially identical Amendment Agreement and Waiver to be executed by [OTHER BUYER], or (c) the substantially
identical Amendment Agreement and Waiver to be executed by [OTHER BUYER] (the parties set forth in clauses (b) and (c) above,
the “Other Buyers” and the agreements set forth in clauses (b) and (c), the “Other Agreements”).

 

9.     
Miscellaneous. In the event that any provision of this Agreement is found to be void or invalid, then such provision shall
be deemed to be severable from the remaining provisions of this Agreement, and it shall not affect the validity of the remaining
provisions, which provisions shall be given full effect as if the void or invalid provision had not been included herein. The
terms and provisions of this Agreement shall inure to the benefit of and be binding upon the heirs, successors and assigns of
the parties. The courts of the State of New York shall have exclusive jurisdiction to resolve any and all disputes that may arise
under this Agreement. Any amendments or modifications hereto must be executed in writing by all parties. Each party hereto shall
do and perform, or cause to be done and performed, all such further acts and things, and shall execute and deliver all such other
agreements, certificates, instruments and documents, as any other party may reasonably request in order to carry out the intent
and accomplish the purposes of this Agreement.

 

10. 
Independent Nature of Buyer’s Obligations and Rights. The obligations of the Buyer under this Agreement are several
and not joint with the obligations of any Other Buyer, and the Buyer shall not be responsible in any way for the performance of
the obligations of any Other Buyer under any Other Agreement. Nothing contained herein or in any Other Agreement, and no action
taken by the Buyer pursuant hereto, shall be deemed to constitute the Buyer and Other Buyers as a partnership, an association,
a joint venture or any other kind of entity, or create a presumption that the Buyer and Other Buyers are in any way acting in
concert or as a group with respect to such obligations or the transactions contemplated by this Agreement or any Other Agreement
and the Company acknowledges that, to the best of its knowledge, the Buyer and the Other Buyers are not acting in concert or as
a group with respect to such obligations or the transactions contemplated by this Agreement or any Other Agreement. The Company
and the Buyer confirm that the Buyer has independently participated in the negotiation of the transactions contemplated hereby
with the advice of its own counsel and advisors. The Buyer shall be entitled to independently protect and enforce its rights,
including, without limitation, the rights arising out of this Agreement, and it shall not be necessary for any Other Buyer to
be joined as an additional party in any proceeding for such purpose.

 

[Remainder
of Page Left Intentionally Blank; Signature Page Follows]

 

    	 	3	 

     

    

 

IN
WITNESS WHEREOF, the parties hereto have executed this Amendment Agreement and Waiver to be effective as of the date determined
in accordance with Section 8 above.

 

	 	COMPANY:
	 	 
	 	ENER-CORE,
    INC.
	 	 	 
	 	By:	             
	 	Name:	Alain
    J. Castro
	 	Title:	Chief
    Executive Officer

 

 

Signature
Page to Amendment Agreement and Waiver

     

     

    

 

IN
WITNESS WHEREOF, the parties hereto have executed this Amendment Agreement and Waiver to be effective as of the date determined
in accordance with Section 8 above.

 

	 	BUYER:

	 	 	 
	 	[BUYER]
	 	 	 
	 	By:	            
	 	Name:	
	 	Title:	

 

 

Signature
Page to Amendment Agreement and Waiver

     

     

    

 

ATTACHMENT
1

 

Form
of Amendment Agreement

 

[Omitted]

 

 

 

Attachment
1EX-4.1

 Exhibit 4.1 

FINAL 
 KUBOTA
PHARMACEUTICAL HOLDINGS CO., LTD. 
 2016-2026 STOCK OPTION PLAN 

(1) Share Acquisition Rights to be Granted under the Kubota Pharmaceutical Holdings Co., Ltd. 2016-2026 Year Stock Option Plan (the
“Plan”) 
 Share acquisition rights issued by Kubota Pharmaceutical Holdings Co., Ltd. (the “Share
Acquisition Rights”) in accordance with this Plan will be either granted as incentive stock options (“ISOs”) within the meaning of Section 422 of the U.S. Internal Revenue Code of 1986, as amended (the
“Code”) or nonstatutory stock options. To the extent that the aggregate fair market value of the shares of Company common stock with respect to which Share Acquisition Rights are exercisable for the first time by the
executive officer or employee during any calendar year (under all plans of the Company and any parent (as defined Section 424(e) of the Code) or subsidiary (as defined Section 424(f) of the Code) exceeds one hundred thousand dollars
($100,000), such Share Acquisition Rights will be treated as nonstatutory stock options. Share Acquisition Rights will be taken into account in the order in which they were granted, the fair market value of the shares will be determined as of the
time the Share Acquisition Right with respect to such shares is granted, and calculation will be performed in accordance with Section 422 of the Code and Treasury Regulations promulgated thereunder. 

(2) Persons to be Granted the Share Acquisition Rights 

All employees, directors and consultants of Kubota Pharmaceutical Holdings Co., Ltd. (the “Company”) and its
subsidiaries within the meaning of Section 424(f) of the Code may be granted Share Acquisition Rights. ISOs may be granted only to employees. 

(3) Type and Total Number of Shares Subject to Share Acquisition Rights 

1,513,313 shares of common stock of the Company may be issued upon the exercise of Share Acquisition Rights and 499,393 shares of common stock
of the Company may be issued upon the exercise of Share Acquisition Rights that are designated as ISOs. 
 In the event of stock split, stock
consolidation, gratis allotment in the shares of common stock of the Company or other similar changes in the capital structure of the Company, the number of shares of common stock of the Company that are subject to the Share Acquisition Rights will
be adjusted using the following formula, subject to any required action by the Company or applicable law; provided, however, that such adjustment shall only apply to the shares of common stock of the Company that are subject to the Share Acquisition
Rights with respect to which the exercise thereof has not yet become effective at the time of such stock split, stock consolidation, gratis allotment in the shares of common stock of the Company or other similar changes in the capital structure of
the Company. Any fraction of a share of common stock of the Company resulting from such adjustment shall be rounded down to the nearest whole share of common stock of the Company. 

									
	 Number of shares of common

stock of the Company
 after
adjustment
	 	=	  	 (Number of shares of common

stock of the Company
 before
adjustment)
	 	x	  	 (ratio of stock split,

stock consolidation,
 gratis
allotment or
 other similar

changes in the
 capital structure
of
 the Company)

 For the purposes of this Plan, “ratio of gratis allotment” means (i) the number of outstanding
shares of the common stock of the Company (excluding the number of treasury shares held by the Company) as of the applicable date of the number of shares of common stock of the Company after adjustment divided by (ii) the number of outstanding
shares of the common stock of the Company (excluding the number of treasury shares held by the Company) as of one day prior to the applicable date of the number of shares of common stock of the Company after adjustment. 

(4) Amount Payable per Share Acquisition Right Upon Grant 

No payment of money is needed. 

(5) Outline of Description and Value of the Asset to be Contributed upon Exercise of Share Acquisition Rights 

The asset to be contributed to the Company upon exercise of Share Acquisition Rights will be cash. 

The value of the asset to be contributed in consideration for one (1) share of common stock of the Company upon exercise of the Share
Acquisition Right (the “Exercise Price”) shall be no less than one hundred percent (100%) of the fair market value of such share on the grant date of the Share Acquisition Rights as determined by the board of directors of the Company.
Share Acquisition Rights granted to executive officers or employees who own stock representing more than ten percent (10%) of the voting power of all classes of stock of the Company or any parent (as defined Section 424(e) of the Code) or
subsidiary (as defined Section 424(f) of the Code), the per share exercise price will be no less than one hundred ten percent (110%) of the fair market value of such share on the grant date of the Share Acquisition Rights as determined by
the board of directors of the Company. 
 Fair market value will be the closing sales price for such stock (or, if no closing sales price was
reported on that date, as applicable, on the last trading date such closing sales price was reported) as quoted on such exchange or system on the day of determination, as reported in a source the board of directors of the Company deem reliable. The
board of directors in its discretion may denominate the exercise price in Yen or US Dollars. 
 In the event of stock split, stock
consolidation, gratis allotment in the shares of common stock of the Company or other similar changes in the capital structure of the Company, the Exercise 

  
 -2- 

 
Price will be adjusted using the following formula, subject to any required action by the Company or applicable law; provided, however, that such adjustment shall only apply to the Exercise Price
of the Share Acquisition Rights that have not been exercised at the time of such stock split, stock consolidation, gratis allotment in the shares of common stock of the Company or other similar changes in the capital structure of the Company. 

 

					
	 Exercise Price after

adjustment
	 	=	  	 Exercise Price before adjustment

	 	  	 Ratio of stock split or stock

consolidation, gratis allotment or

other similar changes in the capital

structure of the Company

 (6) Term of the Plan 

The Plan will become effective upon its adoption by the board of directors of the Company. Unless sooner terminated, the Plan will continue in
effect for a term of ten (10) years from the earlier of (a) the date of adoption of the Plan by the Company’s board of directors or (b) the date that the Plan is approved by the Company’s shareholders. The term of the Share
Acquisition Rights will be no more than ten (10) years from the date of grant thereof. In the case of Share Acquisition Rights granted to an executive officers or employee who, at the time the Share Acquisition Right is granted, owns stock
representing more than ten percent (10%) of the total combined voting power of all classes of stock of the Company or any parent (as defined Section 424(e) of the Code) or subsidiary (as defined Section 424(f) of the Code), the term
of the Share Acquisition Rights will be five (5) years from the date of grant or such shorter term. The Share Acquisition Rights may be exercised only within the term set at the time of grant, and may be exercised during such term only in
accordance with the Plan. 
 (7) Other Terms and Conditions 

The Company can set the other terms and conditions for each issuance of the Share Acquisition Rights under the Plan pursuant to the Companies
Act of Japan and the articles of incorporation of the Company. 
 The Plan will be subject to approval by the stockholders of the Company
within twelve (12) months after the date the Plan is adopted by the Board. Such stockholder approval will be obtained in the manner and to the degree required under applicable laws. 

The Company may at any time amend, alter, suspend or terminate the Plan. The Company will obtain stockholder approval of any Plan amendment to
the extent necessary and desirable to comply with applicable laws. 

  
 -3- 

 ATTACHMENT 

KUBOTA PHARMACEUTICAL HOLDINGS CO., LTD. 

2016-2026 STOCK OPTION PLAN 

FOR 
 EMPLOYEES 

SHARE ACQUISITION RIGHTS AGREEMENT 

Unless otherwise defined herein, the terms defined in the Kubota Pharmaceutical Holdings Co., Ltd. 2016-2026 Stock Option Plan for Employees
(the “Plan”) shall have the same defined meanings in this Share Acquisition Rights Agreement (the “Agreement”). 

I. NOTICE OF SHARE ACQUISITION RIGHTS GRANT 
  

			
	Name of Holder	  	[Name]
		
	Address of Holder	  	[Address]
		
	Type of Share Acquisition Rights:	  	[Series] Share Acquisition Rights
		
	Total Number of Share	  	[Number]
		
	Acquisition Rights:	  	
		
	Exercise Price Per Share:	  	[Applicable exercise price denominated in USD]
		
	Date of Grant:	  	[Date]
		
	Vesting Commencement Date:	  	[Date]
		
	Expiration Date:	  	[Date]
		
	Type of Share Acquisition Right:	  	         These Share Acquisition Rights are intended to qualify as an incentive stock option
within the meaning of Section 422 of the Code.
  

        These Share Acquisition Rights are not intended to qualify as an Incentive Stock Option within the
meaning of Section 422 of the Code and is a nonqualified stock option.

  
 -1- 

			
	
	Vesting Schedule: To the extent permitted by applicable law, the Share Acquisition Rights shall become exercisable, in whole or in part, in accordance with the terms of the Plan and this Agreement:
		
		  	 [One fourth (1/4th) of the shares of Common Stock subject to the Share Acquisition Rights shall become exercisable on the 1 year anniversary
of the Vesting Commencement Date, with one thirty sixth (1/36th) of the remaining shares of Common Stock subject to the Share Acquisition Rights becoming exercisable at the end of each full calendar month thereafter, until all of such shares of
Common Stock are exercisable, provided that the Holder continues to provide Service on such dates.]

		
		  	The Share Acquisition Rights granted hereunder may be subject to other vesting terms including acceleration as set forth in any agreement between the Holder and the Company.

 Termination Period: 

To the extent permitted by applicable law and subject to the terms of the Plan and this Agreement, this Share Acquisition Rights shall be
exercisable for three (3) months after Holder ceases to be a Service Provider, unless such termination is due to Holder’s death or Disability, in which case the Share Acquisition Rights shall be exercisable for twelve (12) months
after Holder ceases to be a Service Provider. Notwithstanding the foregoing sentence, in no event may the Share Acquisition Rights be exercised after the Expiration Date as provided above and the Share Acquisition Rights may be subject to earlier
termination as the Plan and the Share Acquisition Rights Agreement. It is the Holder’s responsibility to exercise the Share Acquisition Rights, if the Share Acquisition Rights so desires, before it expires or terminates. 

II. TERMS AND CONDITIONS OF SHARE ACQUISITION RIGHTS AGREEMENT 

1. Grant of Share Acquisition Rights. The Administrator hereby grants to the person (“Holder”)
named in the Notice of Share Acquisition Rights in Part I of this Agreement (the “Notice”), Share Acquisition Rights at the exercise price per share of Common Stock set forth in the Notice (the “Exercise
Price”), and subject to the terms and conditions of the Plan which is incorporated herein by reference. The terms and conditions of the Share Acquisition Rights (the “Terms and Conditions of the Share Acquisition
Rights”) are set forth in Exhibit A as required under the laws of Japan. In the event of a conflict between the terms and conditions of the Plan, the Terms and Conditions of the Share Acquisition Rights and this Agreement, the
terms and conditions of the Plan shall prevail unless otherwise indicated. Definitions are set forth in Exhibit B. If designated as an ISO, the Share Acquisition Rights are intended to qualify as an Incentive Stock Option under
Section 422 of the Code. At all times the Company shall keep available a sufficient number of shares of Common Stock as shall be required to satisfy the requirements of the Share Acquisition Rights under this Agreement. 

2. Administration. 

(a) This Agreement will be administered by the Administrator. Subject to this Agreement, the Administrator will have full power to implement
and carry out this Agreement. The Administrator will have the authority to: 
 (i) construe and interpret this Agreement; 

(ii) prescribe, amend and rescind rules and regulations relating to the Share Acquisition Rights; 

  
 -2- 

 (iii) determine the number of shares of Common Stock or other consideration subject to Share
Acquisition Rights; 
 (iv) grant waivers of Agreement or conditions with respect to the Share Acquisition Rights; 

(v) determine the vesting, exercisability and payment of the Share Acquisition Rights; 

(vi) correct any defect, supply any omission or reconcile any inconsistency in this Agreement or the Share Acquisition Rights; 

(vii) adopt terms and conditions, rules and procedures relating to the operation and administration of this Agreement to accommodate
requirements of relevant law and procedures; 
 (viii) make all other determinations necessary or advisable for the administration of this
Agreement; and 
 (ix) delegate any of the foregoing to a subcommittee consisting of one or more executive officers pursuant to a specific
delegation as permitted by applicable law. 
 (b) Any determination made by the Administrator with respect to the Share Acquisition Rights
shall be made in its sole discretion, unless in contravention of any express term of this Agreement, at any later time, and such determination shall be final and binding on the Company and all persons having an interest in this Agreement. Any
dispute regarding the interpretation of this Agreement shall be submitted by the Holder or Company to the Administrator for review. The resolution of such a dispute by the Administrator shall be final and binding on the Company and the Holder. The
Administrator may delegate to one or more executive officers the authority to review and resolve disputes with respect to Share Acquisition Rights held by the Holder. 

3. Exercise of Share Acquisition Rights. 

(a) Notwithstanding the Terms and Conditions of the Share Acquisition Rights, the Share Acquisition Rights shall be vested and exercisable, in
whole or in part, according to the vesting schedule specified in the Notice; provided that the Share Acquisition Rights will not be exercisable after the Expiration Date which is 10 years from the Date of Grant. The Share Acquisition Rights may not
be exercised for a fraction of a share of Common Stock. 
 (b) The Share Acquisition Rights are exercisable by delivery of an exercise notice
in a form specified by the Company (the “Exercise Notice”) in the form approved by the Administrator, which shall state, among other things, the election to exercise the Share Acquisition Rights, the number of shares of
Common Stock in respect of which the Share Acquisition Rights is being exercised (the “Exercised Shares”). The Exercise Notice shall be accompanied by payment of the aggregate exercise price as to all Exercised Shares
together with any Tax Related Items. The Exercise Notice shall be effective when it is received by the Company. The Share Acquisition Rights shall be deemed to be exercised upon receipt by the Company of a fully executed Exercise

  
 -3- 

 
Notice accompanied by the aggregate exercise price and any applicable tax withholding due upon exercise of the Share Acquisition Rights. Assuming such compliance, for US income tax purposes or
local law income tax purposes the Exercised Shares will be considered transferred to the Holder on the date the Share Acquisition Rights are exercised with respect to such Exercised Shares. 

(c) If another person wants to exercise the Share Acquisition Rights after they have been transferred to him or her that person must prove to
the Company’s satisfaction that he or she is entitled to exercise the Share Acquisition Rights. That person must also complete the proper Exercise Notice form and pay the exercise price and any applicable tax withholding due upon exercise of
the Share Acquisition Rights. 
 (d) Shares of Common Stock issued upon exercise of the Share Acquisition Rights will be issued in the name
of the Holder. 
 (e) No shares of Common Stock will be issued pursuant to the exercise of the Share Acquisition Rights unless such issuance
and exercise complies with all applicable U.S. and foreign federal and state securities and exchange control laws, rules and regulations of any governmental body, including without limitation all applicable laws and regulations and all applicable
requirements of any stock exchange or automated quotation system on which the shares of Common Stock may be listed or quoted at the time of such issuance. Notwithstanding any other provision in this Agreement, the Company will have no obligation to
issue the shares of Common Stock under this Agreement prior to: (i) obtaining any approvals from governmental agencies that the Company determines are necessary or advisable; and/or (ii) completion of any registration or other
qualification of such shares of Common Stock under any state or federal or foreign law or ruling of any governmental body that the Company determines to be necessary or advisable. The Company will be under no obligation to register the shares of
Common Stock with the SEC or to effect compliance with the registration, qualification or listing requirements of any foreign or state securities laws, exchange control laws, stock exchange or automated quotation system, and the Company will have no
liability for any inability or failure to do so. 
 (f) To the extent required by applicable law, the Company shall furnish to the Holder the
Company’s summary financial information including balance sheet regarding the Company’s financial condition and results of operations, unless such Holder has duties with the Company that assure them access to equivalent information. Such
financial statements need not be audited. 
 4. Method of Payment. Payment of the aggregate exercise price shall be by
cash. 
 5. Termination. 

(a) The Holder’s Service will be considered terminated as of the date the Holder is no longer providing Services to the Company, its
Parent or one of its Subsidiaries (regardless of the reason for such termination and whether or not later found to be invalid or in breach of employment laws in the jurisdiction where the Holder is employed or the terms of the Holder’s
employment agreement, if any) (the “Termination Date”). The Administrator shall have the exclusive discretion to determine when the Holder is no longer actively providing Services for

  
 -4- 

 
purposes of this Agreement (including whether the Holder may still be considered to be providing Services while on an approved leave of absence). The Holder’s right to vest in any Share
Acquisition Right under this Agreement, if any, will terminate as of the Termination Date and will not be extended by any notice period (e.g., the Holder’s period of Services would not include any contractual notice period or any period of
“garden leave” or similar period mandated under employment laws in the jurisdiction where the Holder are employed or the terms of the Holder’s employment agreement, if any). Following the Termination Date, the Holder may exercise any
Share Acquisition Right only as set forth in this Agreement, provided that the period (if any) during which the Holder may exercise any Share Acquisition Right after the Termination Date, if any, will commence on the date the Holder ceases to
provide Services and will not be extended by any notice period mandated under employment laws in the jurisdiction where the Holder is employed or terms of the Holder’s employment agreement, if any. If the Holder does not exercise any Share
Acquisition Rights within the Termination Period set forth in the Notice, all Share Acquisition Rights shall terminate in their entirety. In no event, may any Share Acquisition Right be exercised after the Expiration Date. 

(b) In the event Share Acquisition Rights terminate or expire for any reasons, including those set forth in Sections 5 (a) and 6, all such
Share Acquisition Rights shall be deemed to have been waived by the Holder. 
 6. Termination Period. 

(a) If the Holder’s Service terminates for any reason except death or Disability, and other than for Cause, then the Share Acquisition
Rights will expire at the close of business at Company headquarters on the date three months after the Holder’s Termination Date. 
 (b)
Unless otherwise provided in the Plan, the Terms and Conditions of the Share Acquisition Rights or this Agreement, if the Holder dies before the Holder’s Service terminates, then the Share Acquisition Rights will expire at the close of business
at Company headquarters on the date 12 months after the date of death. If the Holder’s Service terminates because of the Holder’s Disability, then the Share Acquisition Rights will expire at the close of business at Company headquarters on
the date 12 months after the Holder’s Termination Date. 
 (c) Unless otherwise provided in the Notice, if the Holder is terminated for
Cause, then the Holder’s Share Acquisition Rights shall expire on the Holder’s date of termination of Service, or at such later time and on such conditions as are determined by the Company, but in any no event later than the Expiration
Date of the Share Acquisition Rights as set forth in the Notice. The determination as to whether a Holder is being terminated for Cause shall be made in good faith by the Company and shall be final and binding on the Holder. 

(d) The Holder is responsible for keeping track of these exercise periods following the Holder’s termination of Service for any reason as
set forth in this Agreement. The Company will not provide further notice of such periods. In no event shall the Share Acquisition Rights be exercised later than the Expiration Date. 

  
 -5- 

 7. ISOs. 

(a) If a Share Acquisition Right is an ISO, to the extent that the aggregate Fair Market Value of the shares of Common Stock with respect to
which such ISOs are exercisable for the first time by the Holder during any calendar year (under all plans of the Company and any Parent or Subsidiary) exceeds one hundred thousand dollars ($100,000), such Share Acquisition Rights will be treated as
NSOs. ISOs will be taken into account in the order in which they were granted. The Fair Market Value of the shares of Common Stock will be determined as of the time the Share Acquisition Rights with respect to such shares of Common Stock is granted.
In the event that the Code or the regulations promulgated thereunder are amended after the Date of Grant to provide for a different limit on the Fair Market Value of shares of Common Stock permitted to be subject to ISOs, such different limit will
be automatically incorporated herein and will apply to any Share Acquisition Right granted after the effective date of such amendment. 
 (b)
Notwithstanding any other provision in this Agreement, no term of this Agreement relating to ISOs will be interpreted, amended or altered, nor will any discretion or authority granted under this Agreement be exercised, so as to disqualify this
Agreement under Section 422 of the Code or, without the consent of the Holder affected, to disqualify any ISO under Section 422 of the Code. 

8. Non-Transferability of Share Acquisition Rights. 

(a) The Share Acquisition Rights may not be sold, pledged, assigned, hypothecated, transferred, or disposed of in any manner other than by will
or by the laws of descent or distribution. Unless otherwise provided in this Section 8, all Share Acquisition Rights shall be exercisable: (i) during the Holder’s lifetime only by (A) the Holder, or (B) the Holder’s guardian
or legal representative; or (ii) after the Holder’s death, by the legal representative of the Holder’s heirs or legatees. 

(b) However, if a Share Acquisition Right is designated as a NSO, then the Company may, in its sole discretion, allow the Holder to transfer
such Share Acquisition Right as a gift to one or more family members. For purposes of this Agreement, “family member” means a child, stepchild, grandchild, parent, stepparent, grandparent, spouse, former spouse, sibling, niece, nephew,
mother-in- law, father-in-law, son-in-law, daughter-in-law, brother-in-law or sister-in-law (including adoptive relationships), any individual sharing the Holder’s household (other than a tenant or employee), a trust in which one or more of
these individuals have more than 50% of the beneficial interest, a foundation in which the Holder or one or more of these persons control the management of assets, and any entity in which the Holder or one or more of these persons own more than 50%
of the voting interest. In addition, if any Share Acquisition Right is designated an NSO, then the Company may, in its sole discretion, allow the Holder to transfer the Share Acquisition Rights to the Holder’s spouse or former spouse pursuant
to a domestic relations order in settlement of marital property rights. The Company will allow the Holder to transfer such Share Acquisition Rights only if both the Holder and the transferee(s) execute the forms prescribed by the Company, which
include the consent of the transferee(s) to be bound by this Agreement. The terms of this Agreement shall be binding upon the executors, administrators, heirs, successors and assigns of the Holder. 

  
 -6- 

 9. Adjustment of Shares of Common Stock. If the number of outstanding shares
of Common Stock is changed by a stock dividend, recapitalization, stock split, reverse stock split, subdivision, combination, reclassification or similar change in the capital structure of the Company, without consideration, then the exercise prices
of and number of shares of Common Stock subject to outstanding Share Acquisition Rights shall be proportionately adjusted pursuant to the applicable provisions of the Plan and the Terms and Conditions of the Share Acquisition Rights; provided that
fractions of a share of Common Stock will not be issued. 
 10. Corporate Transactions. In the event of a Corporate
Transaction, Share Acquisition Rights need not be treated similarly in a Corporate Transaction and: 
 (a) any or all Share Acquisition
Rights may be assumed or replaced by the successor corporation, which assumption or replacement shall be binding on the Holder; 
 (b) the
successor corporation may substitute equivalent Share Acquisition Rights or provide substantially similar consideration to the Holder as was provided to stockholders (after taking into account the existing provisions of the Share Acquisition
Rights); 
 (c) in the event such successor or acquiring corporation (if any) refuses to assume, convert, replace or substitute Share
Acquisition Rights, as provided in this Agreement, pursuant to a Corporate Transaction, (I) then notwithstanding any other provision in this Agreement to the contrary, such Share Acquisition Rights will expire on such transaction at such time
and on such conditions as the Administrator will determine and (II) the Administrator will notify the Holder in writing or electronically that such Share Acquisition Rights will be exercisable for a period of time determined by the Administrator in
its sole discretion, and such Share Acquisition Right will terminate upon the expiration of such period; or 
 (d) the Administrator may, in
its sole discretion, accelerate the vesting of any Share Acquisition Rights in connection with a Corporate Transaction; 
 11. Tax
Consequences. The Holder should consult a tax advisor for tax consequences relating to the Share Acquisition Rights in the jurisdiction in which the Holder is subject to tax. The Holder acknowledges that, regardless of any action taken
by the Company or, if different, the Holder’s employer (the “Employer”) the ultimate liability for all income tax, social insurance, payroll tax, fringe benefits tax, payment on account or other tax-related items related
to the Holder’s Share Acquisition Rights and legally applicable to the Holder (“Tax-Related Items”), is and remains the Holder’s responsibility and may exceed the amount actually withheld by the Company or the
Employer. The Holder further acknowledge that the Company and/or the Employer (a) make no representations or undertakings regarding the treatment of any Tax-Related Items in connection with any aspect of the Share Acquisition Rights, including,
but not limited to, the grant, vesting or exercise of the Share Acquisition Rights, the subsequent sale of shares of Common Stock acquired pursuant to such exercise and the receipt of any dividends; and (b) do not commit to and are under no
obligation to structure the terms of the grant or any aspect of the Share Acquisition Rights to reduce or eliminate the Holder’s liability for Tax-Related Items or achieve any particular tax result. Further, the Holder acknowledges that the
Company and/or the Employer (or former employer, as applicable) may be required to withhold or account for Tax-Related Items in more than one jurisdiction. THE HOLDER SHOULD CONSULT A TAX ADVISER APPROPRIATELY QUALIFIED IN THE COUNTRY OR
COUNTRIES IN WHICH THE HOLDER RESIDES OR IS SUBJECT TO TAXATION BEFORE EXERCISING THE SHARE ACQUISITION RIGHTS OR DISPOSING OF THE SHARES. 

  
 -7- 

 12. Withholding Taxes. 

(a) Prior to exercise of the Share Acquisition Rights, the Holder shall pay or make adequate arrangements satisfactory to the Company and/or
the Employer to satisfy all withholding and payment on account obligations of the Company and/or the Employer in accordance with applicable law. In this regard, to the extent permitted by applicable law, the Holder authorizes the Company and/or the
Employer to withhold all applicable Tax-Related Items legally payable by the Holder (i) from the Holder’s wages or other cash compensation paid to the Holder by the Company and/or the Employer or (ii) by means of any other arrangement
approved by the Company. The Holder shall pay to the Company or the Employer any amount of Tax-Related Items that the Company or the Employer may be required to withhold as a result of the Holder’s purchase of shares of Common Stock that cannot
be satisfied by the means previously described. The Company may refuse to honor the exercise and refuse to deliver the shares of Common Stock if the Holder fails to comply with the Holder’s obligations in connection with the Tax-Related Items
as described in this Section. 
 (b) Depending on the withholding method, the Company may withhold or account for Tax-Related Items by
considering applicable minimum statutory withholding amounts or other applicable withholding rates, including maximum applicable rates, in which case the Holder will receive a refund of any over-withheld amount in cash and will have no entitlement
to the Common Stock equivalent. 
 (c) For U.S. taxpayers, if the Holder sells or otherwise disposes of any of the shares of Common Stock
acquired pursuant to an ISO on or before the later of (i) two years after the Date of Grant, or (ii) one year after the exercise date, the Holder will immediately notify the Company in writing of such disposition. The Holder agrees that
the Holder may be subject to income tax withholding by the Company on the compensation income recognized from such early disposition of ISO shares of Common Stock by payment in cash or out of the current earnings paid to the Company. 

13. Acknowledgement. The Company and the Holder agree that the Share Acquisition Rights are granted under and governed
under the terms of this Agreement, the Terms and Conditions of the Share Acquisition Rights and the Plan. The Holder: (a) acknowledges receipt of a copy of this Agreement, the Terms and Conditions of the Share Acquisition Rights and the Plan,
(b) represents that the Holder has carefully read and is familiar with their provisions, and (c) hereby accepts the Share Acquisition Rights subject to all of the terms and conditions set forth in this Agreement, the Terms and Conditions
of the Share Acquisition Rights and the Plan. The Holder hereby agrees to accept as binding, conclusive and final all decisions or interpretations of the Company upon any questions relating to this Agreement. 

14. Voting and Dividends. The Holder will not have any of the rights of a stockholder with respect to any shares of Common
Stock until the shares of Common Stock are issued to the Holder. After shares of Common Stock are issued to the Holder, the Holder will be a stockholder and have all the rights of a stockholder with respect to such shares of Common Stock, including
the right to vote and receive all dividends or other distributions made or paid with respect to such shares of Common Stock. 

  
 -8- 

 15. Certificates. Unless otherwise provided by the Administrator, the
Company shall not issue any certificates. All shares of Common Stock or other securities whether or not certificated, delivered under this Agreement will be subject to such stock transfer orders, legends and other restrictions as the Administrator
may deem necessary or advisable, including restrictions under any applicable U.S. federal, state or foreign securities law, or any rules, regulations and other requirements of the SEC or any stock exchange or automated quotation system upon which
the shares of Common Stock may be listed or quoted and any non-U.S. exchange controls or securities law restrictions to which the shares of Common Stock are subject. 

16. Insider Trading Restrictions/Market Abuse Laws. The Holder shall comply with any policy adopted by the Company from
time to time covering transactions in the Company’s securities by Employees, officers and/or directors of the Company, and depending on his or her country, Holder may now or in the future be subject to insider trading restrictions and/or market
abuse laws, which may affect his or her ability to acquire or sell shares of Common Stock under this Agreement during such times as the Holder is considered to have “inside information” or “material fact” regarding the Company
(as defined by the laws in Holder’s country or in Japan). Any restrictions under these laws or regulations are separate from and in addition to any restrictions that may be imposed under any applicable Company insider trading policy. 

17. Imposition of Other Requirements. The Company reserves the right to impose other requirements on the Share Acquisition
Rights and on any shares of Common Stock purchased upon exercise of the Share Acquisition Rights, to the extent the Company determines it is necessary or advisable for legal or administrative reasons, and to require the Holder to sign any additional
agreements or undertakings that may be necessary to accomplish the foregoing. The Parties agree to execute such further documents and instruments and to take such further actions as may be reasonably necessary to carry out the purposes and intent of
this Agreement. 
 18. Disposition of Shares. Holder hereby agrees that upon exercise, Holder shall make no
disposition of the shares of Common Stock (other than as permitted by this Agreement) unless and until: 
 (a) Holder shall have notified the
Company of the proposed disposition and provided a written summary of the terms and conditions of the proposed disposition; 
 (b) Holder
shall have complied with all requirements of this Agreement applicable to the disposition of the Shares; and 
 (c) Holder shall have
provided the Company with written assurances, in form and substance satisfactory to counsel for the Company, that (i) the proposed disposition does not require registration of the shares of Common Stock under the Securities Act or (ii) all
appropriate actions necessary for compliance with the registration requirements of the Securities Act or of any exemption from registration available under the Securities Act have been taken. 

  
 -9- 

 19. Appendix. Notwithstanding any provisions in this Agreement, the Share
Acquisition Rights grant shall be subject to any special terms and conditions set forth in the Exhibit B for the Holder’s country. 

20. Consent to Electronic Delivery of Documents and Disclosures; Language. By the Holder’s acceptance of the Share
Acquisition Rights, the Holder consents to the electronic delivery of this Agreement and any applicable documents including account statements, U.S. financial reports of the Company, and all other documents that the Company is required to deliver to
its security holders (including, without limitation, annual reports and proxy statements) or other communications or information related to the Share Acquisition Rights. Electronic delivery may include the delivery of a link to a Company intranet,
the delivery of the document via e-mail or such other delivery determined at the Company’s discretion. The Holder acknowledges that the Holder may receive from the Company a paper copy of any documents delivered electronically at no cost if the
Holder contacts the Company by telephone, through a postal service or electronic mail. The Holder further acknowledges that the Holder will be provided with a paper copy of any documents delivered electronically if electronic delivery fails;
similarly, the Holder understands that the Holder must provide on request to the Company or any designated third party a paper copy of any documents delivered electronically if electronic delivery fails. Also, the Holder understands that the
Holder’s consent may be revoked or changed, including any change in the electronic mail address to which documents are delivered (if the Holder has provided an electronic mail address), at any time by notifying the Company of such revised or
revoked consent by telephone, postal service or electronic mail. Finally, the Holder understands that the Holder is not required to consent to electronic delivery. To the extent the Holder has been provided with a copy of this Agreement or any other
documents relating to the grant in a language other than English, the English language documents will prevail in case of any ambiguities or divergences as a result of translation; provided, however, that the Plan in Japanese will prevail the Plan in
a language other than Japanese, and the Terms and Conditions of the Share Acquisition Rights will prevail in a language other than Japanese. 

21. No Rights as Employee. Nothing in this Agreement shall affect in any manner whatsoever the right or power of the
Company, or a Parent or Subsidiary of the Company, to terminate the Holder’s Service, for any reason, with or without Cause. 
 22.
Data Privacy. 
 (a) The Holder hereby explicitly and unambiguously consents to the collection, use and transfer, in
electronic or other form, of the Holder’s personal data as described in this Agreement and any other grant materials by and among, as applicable, the Employer, the Company and its Parent, and Subsidiaries for the exclusive purpose of
implementing, administering and managing the Holder’s Share Acquisition Rights (the “Data”). 
 (b) The Holder
understands that the Company and the Employer may hold certain personal information about the Holder, including, but not limited to, the Holder’s name, home address and telephone number, date of birth, social insurance number or other
identification number (if any), salary, nationality, job title, any shares of stock or directorships held in the Company, details of all Share Acquisition Rights or any other entitlement to shares of Common Stock awarded, canceled, exercised,
vested, unvested or outstanding in the Holder’s favor, for the exclusive purpose of implementing, administering and managing the Share Acquisition Rights. 

  
 -10- 

 (c) The Holder understands that Data may be transferred to a Company-designated broker or such
other stock plan service provider as may be selected by the Company in the future, which is assisting the Company with the implementation, administration and management of the Share Acquisition Rights. The Holder understands that the recipients of
the Data may be located in Japan, the United States or elsewhere, and that the recipient’s country (e.g., Japan, the United States) may have different data privacy laws and protections than the Holder’s country. The Holder understands that
the Holder may request a list with the names and addresses of any potential recipients of the Data by contacting the Holder’s local human resources representative. The Holder authorizes the Company, its designated broker and any other possible
recipients which may assist the Company (presently or in the future) with implementing, administering and managing the Share Acquisition Rights to receive, possess, use, retain and transfer the Data, in electronic or other form, for the sole
purposes of implementing, administering and managing the Holder’s Share Acquisition Rights. The Holder understands that Data will be held only as long as is necessary to implement, administer and manage the Holder’s Share Acquisition
Rights. The Holder understands that the Holder may, at any time, view Data, request additional information about the storage and processing of Data, require any necessary amendments to Data or refuse or withdraw the consents herein, in any case
without cost, by contacting in writing the Holder’s local human resources representative. Further, the Holder understands that the Holder is providing the consents herein on a purely voluntary basis. If the Holder does not consent, or if the
Holder later seeks to revoke the Holder’s consent, the Holder’s employment status or service and career with the Employer will not be adversely affected; the only adverse consequence of refusing or withdrawing the Holder’s consent is
that the Company would not be able to grant the Holder options or other equity awards or administer or maintain such awards. Therefore, the Holder understands that refusing or withdrawing the Holder’s consent may affect the Holder’s
ability to receive the compensation through the Share Acquisition Rights. For more information on the consequences of the Holder’s refusal to consent or withdrawal of consent, the Holder understands that the Holder may contact the Holder’s
local human resources representative. 
 23. Nature of Grant. In accepting the Share Acquisition Rights, the Holder
acknowledges, understand and agree that: 
 (a) the grant of the Share Acquisition Rights are voluntary and occasional and does not create
any contractual or other right to receive future grants of options, stock acquisition rights, or benefits in lieu of options, even if options have been granted in the past; 

(b) all decisions with respect to future options, stock acquisition rights or other grants, if any, will be at the sole discretion of the
Company; 
 (c) the Share Acquisition Rights shall not create a right to employment or be interpreted as forming an employment or service
contract with the Company, the Employer or any Parent, or Subsidiary, and shall not interfere with the ability of the Company, the Employer or any Parent, or Subsidiary, as applicable, to terminate the Holder’s employment or service
relationship (if any); 

  
 -11- 

 (d) the Share Acquisition Rights and any shares of Common Stock acquired as a result of the
exercise of the Share Acquisition Rights are not intended to replace any pension rights or compensation; 
 (e) the Share Acquisition Rights
and any shares of Common Stock acquired as a result of the exercise of the Share Acquisition Rights and the income and value of same, are not part of normal or expected compensation for purposes of calculating any severance, resignation,
termination, redundancy, dismissal, end-of-service payments, bonuses, long-service awards, pension or retirement or welfare benefits or similar payments; 

(f) the future value of the shares of Common Stock underlying the Share Acquisition Rights is unknown, indeterminable, and cannot be predicted
with certainty; 
 (g) if the underlying shares of Common Stock do not increase in value, the Share Acquisition Rights will have no value;

 (h) if the Holder exercises any Share Acquisition Right and acquire shares of Common Stock, the value of such shares of Common Stock may
increase or decrease in value, even below the exercise price; 
 (i) no claim or entitlement to compensation or damages shall arise from
forfeiture of the Share Acquisition Rights resulting from the Holder ceasing to provide Services to the Company or the Employer (for any reason whatsoever, whether or not later found to be invalid or in breach of employment laws in the jurisdiction
where the Holder is employed or the terms of the Holder’s employment agreement, if any), and in consideration of the grant of the Share Acquisition Rights to which the Holder is otherwise not entitled, the Holder irrevocably agrees never to
institute any claim against the Company, its Parent, any of its Subsidiaries or the Employer, waive the Holder’s ability, if any, to bring any such claim, and release the Company, its Parent, Subsidiaries and the Employer from any such claim;
if, notwithstanding the foregoing, any such claim is allowed by a court of competent jurisdiction, then, Holder hereby irrevocably agrees not to pursue such claim and agrees to execute any and all documents necessary to request dismissal or
withdrawal of such claim; 
 (j) unless otherwise provided by the Company in its discretion, the Share Acquisition Rights and the benefits
evidenced by this Agreement do not create any entitlement to have the Share Acquisition Rights or any such benefits transferred to, or assumed by, another company nor to be exchanged, cashed out or substituted for, in connection with any corporate
transaction affecting the shares of Common Stock; 
 (k) the Share Acquisition Rights and the shares of Common Stock subject to the Share
Acquisition Rights are not part of normal or expected compensation or salary for any purpose; and 
 (l) the Holder acknowledges and agrees
that neither the Company, the Employer nor any Parent, or Subsidiary shall be liable for any foreign exchange rate fluctuation between the Holder’s local currency and the United States Dollar or Japanese yen that may affect the value of the
Share Acquisition Rights or of any amounts due to the Holder pursuant to the exercise of the Share Acquisition Rights or the subsequent sale of any shares of Common Stock acquired upon exercise. 

  
 -12- 

 24. Entire Agreement. This Agreement, the Terms and Conditions of the Share
Acquisition Rights and the Plan constitute the entire agreement and understanding of the parties relating to the subject matter herein and supersede all prior discussions between them. Any prior agreements, commitments or negotiations concerning the
purchase of the shares of Common Stock hereunder are superseded. No modification of or amendment to this Agreement, nor any waiver of any rights under this Agreement, will be effective unless in writing and signed by the parties to this Agreement
unless the Agreement permits the Administrator to amend such provision without the consent of the Holder. The failure by either party to enforce any rights under this Agreement will not be construed as a waiver of any rights of such party. 

25. Governing Law; Venue; Severability. If one or more provisions of this Agreement are held to be unenforceable under
applicable law, the parties agree to renegotiate such provision in good faith. In the event that the parties cannot reach a mutually agreeable and enforceable replacement for such provision, then (a) such provision shall be excluded from this
Agreement, (b) the balance of this Agreement shall be interpreted as if such provision were so excluded and (c) the balance of this Agreement shall be enforceable in accordance with its terms. This Agreement and all acts and transactions
pursuant hereto and the rights and obligations of the parties hereto shall be governed, construed and interpreted in accordance with the laws of Japan, without giving effect to principles of conflicts of law. Any and all disputes relating to,
concerning or arising from this Agreement, or relating to, concerning or arising from the relationship between the parties evidenced by this Agreement, will be brought and heard exclusively in the Tokyo District Court. Each of the parties hereby
represents and agrees that such party is subject to the personal jurisdiction of said courts; hereby irrevocably consents to the jurisdiction of such courts in any legal or equitable proceedings related to, concerning or arising from such dispute,
and waives, to the fullest extent permitted by law, any objection which such party may now or hereafter have that the laying of the venue of any legal or equitable proceedings related to, concerning or arising from such dispute which is brought in
such courts is improper or that such proceedings have been brought in an inconvenient forum. 

  
 -13- 

 Holder acknowledges receipt of a copy of the Plan and represents that he or she is familiar with the terms and
provisions thereof, and hereby accepts the Share Acquisition Rights subject to the terms and conditions of the Plan, the Terms and Conditions of the Share Acquisition Rights and this Agreement, all of which are made a part of this document. Holder
has reviewed the Plan, the Terms and Conditions of the Share Acquisition Rights and the Share Acquisition Rights in their entirety, has had an opportunity to obtain the advice of counsel prior to executing the Share Acquisition Rights and fully
understands all provisions of the Share Acquisition Rights. Holder hereby agrees to accept as binding, conclusive and final all decisions or interpretations of the Administrator upon any questions arising under the Plan, the Terms and Conditions of
the Share Acquisition Rights or the Share Acquisition Rights. Holder further agrees to notify the Company upon any change in the residence address indicated below. This Share Acquisition Rights Agreement does not represent a securities interest in
the Company, which interest may accrue only upon the exercise of the Share Acquisition Rights in accordance with its terms. 
  

									
	HOLDER	 		 	 KUBOTA PHARMACEUTICAL

HOLDINGS CO., LTD.

					
	Signature:	 	 	 		 	By:	 	 
					
	Print Name:	 	 	 		 	Its:	 	 

  
 -1- 

 EXHIBIT B 

TERMS AND CONDITIONS OF SERIES [●] SHARE ACQUISITION RIGHTS 

 EXHIBIT B 

DEFINITIONS 
 Capitalized
terms used in this Agreement and the Plan shall have the following meanings below unless otherwise defined: 
 (a)
“Administrator” means the Board. 
 (b) “Board” means the board of directors of the Company.

 (c) “Cause” unless otherwise provided in an agreement between the Holder and the Company Cause means, unless
otherwise defined in an agreement between the Holder and the Company, (I) Holder’s willful failure substantially to perform his or her duties and responsibilities to the Company or deliberate violation of a Company policy;
(II) Holder’s commission of any act of fraud, embezzlement, dishonesty or any other willful misconduct that has caused or is reasonably expected to result in material injury to the Company; (III) unauthorized use or disclosure by
Holder of any proprietary information or trade secrets of the Company or any other party to whom the Holder owes an obligation of nondisclosure as a result of his or her relationship with the Company; or (IV) Holder’s willful breach of any
of his or her obligations under any written agreement or covenant with the Company; 
 (d) “Code” means the United
States Internal Revenue Code of 1986, as amended, and the regulations promulgated thereunder. 
 (e) “Common Stock”
means the common stock of the Company. 
 (f) “Consultant” means any person, including an advisor or independent
contractor, engaged by the Company or a Parent or Subsidiary to render services to such entity. 
 (g) “Corporate
Transaction” means the occurrence of any of the following events: (I) any “person” (as such term is used in Sections 13(d) and 14(d) of the Exchange Act) becomes the “beneficial owner” (as defined in Rule 13d-3
of the Exchange Act), directly or indirectly, of securities of the Company representing more than fifty percent (50%) of the total voting power represented by the Company’s then-outstanding voting securities; provided, however, that for
purposes of this subclause (I) the acquisition of additional securities by any one person who is considered to own more than fifty percent (50%) of the total voting power of the securities of the Company will not be considered a Corporate
Transaction; (II) the consummation of the sale or disposition by the Company of all or substantially all of the Company’s assets; (III) the consummation of a merger or consolidation of the Company with any other corporation, other
than a merger or consolidation which would result in the voting securities of the Company outstanding immediately prior thereto continuing to represent (either by remaining outstanding or by being converted into voting securities of the surviving
entity or its parent) at least fifty percent (50%) of the total voting power represented by the voting securities of the Company or such surviving entity or its parent outstanding immediately after such merger or consolidation; (IV) any
other transaction which qualifies as a “corporate transaction” under Section 424(a) of the Code wherein the 

  
 -1- 

 
stockholders of the Company give up all of their equity interest in the Company (except for the acquisition, sale or transfer of all or substantially all of the outstanding shares of the Company)
or (V) a change in the effective control of the Company that occurs on the date that a majority of members of the Board is replaced during any twelve (12) month period by member of the Board whose appointment or election is not endorsed by
as majority of the members of the Board prior to the date of the appointment or election. For purpose of this subclause (V), if any person is considered to be in effective control of the Company, the acquisition of additional control of the Company
by the same person will not be considered a Corporate Transaction; provided, however, that, a transaction will not be deemed a Corporate Transaction unless the transaction qualifies as a change in control event within the meaning of Code
Section 409A, as it has been and may be amended from time to time, and any proposed or final Treasury Regulations and Internal Revenue Service guidance that has been promulgated or may be promulgated thereunder from time to time (For purposes
of this definition, persons will be considered to be acting as a group if they are owners of a corporation that enters into a merger, consolidation, purchase or acquisition of stock, or similar business transaction with the Company). 

(h) “Director” means a member of the Board. 

(i) “Disability” Disability means, unless otherwise defined in an agreement between the Holder and the Company, in the
case of incentive stock options, total and permanent disability as defined in Section 22(e)(3) of the Code and in the case of other Share Acquisition Rights, that the Holder is unable to engage in any substantial gainful activity by reason of
any medically determinable physical or mental impairment that can be expected to result in death or can be expected to last for a continuous period of not less than 12 months; 

(j) “Employee” means any person, including officers and directors, providing Services as an employee to the Company or
any Parent or Subsidiary of the Company; provided, however, neither service as a Director nor payment of a director’s fee by the Company will be sufficient to constitute “employment” by the Company. 

(k) “Exchange Act” means the United States Securities Exchange Act of 1934, as amended. 

(l) “Fair Market Value” means, as of any date, the value of a share of the Common Stock determined as follows: 

(i) if such shares of Common Stock is publicly traded and is then listed on Tokyo Stock Exchange, its closing price on the date of
determination on Tokyo Stock Exchange on which the shares of Common Stock is listed or admitted to trading as reported in Nihon Keizai Shinbun or such other source as the Administrator deems reliable; 

(ii) if such shares of Common Stock is publicly traded but is neither listed nor admitted to trading on a national securities exchange, the
average of the closing bid and asked prices on the date of determination as reported in such source as the Administrator deems reliable; or 

  
 -2- 

 (iii) if none of the foregoing is applicable, by the Administrator in good faith. 

(m) “Good Reason” means, unless otherwise defined in an agreement between the Holder and the Company, the occurrence of
any of the following, in each case taken without the Holder’s written consent: (i) a material reduction in the Holder’s duties, authority or responsibilities, it being understood that a reduction in the Holder’s responsibilities
or authority shall not constitute Good Reason if there is no demotion in the Holder’s title or position or reduction of the scope of the Holder’s duties within the Company; (ii) a material reduction in the Holder’s base salary
(and for purposes hereof, “material” means a reduction greater than 10% other than an equivalent percentage reduction in annual base salaries that applies to similarly situated employees of the Company); or (iii) the relocation of the
Company’s principal place of business to a location that is outside a 50 mile radius of the Company’s principal place of business as of the date immediately prior to such relocation. Notwithstanding the foregoing, the Holder cannot
terminate the Holder’s employment for Good Reason unless the Holder (A) has provided written notice to the Company of the existence of the circumstances providing grounds for termination for Good Reason within thirty (30) calendar
days of the initial existence of such grounds, (B) the Company has failed to cure such circumstances within thirty (30) calendar days after receipt of such notice, and (C) the Holder resigns the Holder’s employment within thirty
(30) calendar days of such 30-day cure period. 
 (n) “ISO” means an incentive stock option described in Code
Section 422(b). 
 (o) “NSO” means a Share Acquisition Rights that is not an ISO. 

(p) “Parent” means any corporation (other than the Company) in an unbroken chain of corporations ending with the
Company if each of such corporations other than the Company owns stock possessing fifty percent (50%) or more of the total combined voting power of all classes of stock in one of the other corporations in such chain. 

(q) “Securities Act” means the United States Securities Act of 1933, as amended. 

(r) “Service” means service as an Employee. An Employee will not be deemed to have ceased to provide Service in the
case of (i) sick leave, (ii) military leave, or (iii) any other leave of absence approved by the Administrator; provided, that such leave is for a period of not more than 90 days, unless reemployment upon the expiration of such leave
is guaranteed by contract or statute or unless provided otherwise pursuant to formal policy adopted from time to time by the Board and issued and promulgated to employees in writing. In the case of any Employee on an approved leave of absence, the
Administrator may make such provisions respecting suspension of vesting of a Share Acquisition Right while on leave from the employ of the Company or a Parent or Subsidiary of the Company as it may deem appropriate, except that in no event may a
Share Acquisition Right be exercised after the Expiration Date. In the event of military leave, if required by applicable laws, vesting shall continue for the longest period that vesting continues under any other statutory or Company approved leave
of absence and, upon a Holder’s returning from military leave (under conditions that would entitle him or her to protection upon such return under the Uniform Services Employment and Reemployment Rights Act), he or she shall be given vesting
credit with respect to Share Acquisition Rights to the same extent as would have applied had the 

  
 -3- 

 
Holder continued to provide services to the Company throughout the leave on the same terms as he or she was providing services immediately prior to such leave. An Employee shall have terminated
employment as of the date he or she ceases to provide services (regardless of whether the termination is in breach of local employment laws or is later found to be invalid) and employment shall not be extended by any notice period or garden leave
mandated by local law, provided however, that a change in status from an employee to a consultant or advisor shall not terminate the service provider’s Service, unless determined by the Administrator, in its discretion. The Administrator will
have sole discretion to determine whether a Holder has ceased to provide Services and the effective date on which the Holder ceased to provide Services. 

(s) “Subsidiary” means any corporation (other than the Company) in an unbroken chain of
corporations beginning with the Company if each of the corporations other than the last corporation in the unbroken chain owns stock possessing fifty percent (50%) or more of the total combined voting power of all classes of stock in one of the
other corporations in such chain 

  
 -4- 

 EXHIBIT C 

COUNTRY SPECIFIC PROVISIONS

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00264-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00264-of-00352.parquet"}]]